Comparison of del Nido and histidine-tryptophan-ketoglutarate cardioplegic solutions in minimally invasive cardiac surgery
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- Nature IndexSCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY164(4) · pp.E161 · 2022
- 피인용
- Web of Science 19Scopus 21
- FWCI (Scopus)
- 1.69
- JCR IF
- JCR 2021 6.439
- ISSN
- 0022-5223
저자
- 이치훈제1저자Pusan Natl Univ, Res Inst Convergence Biomed Sci & Technol, Dept Cardiovasc & Thorac Surg, Yangsan Hosp, Seoul, South Korea
- Kwon, YoungkernUniv Ulsan, Coll Med, Asan Med Ctr, Dept Thorac & Cardiovasc Surg, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
- Park, Sung JunUniv Ulsan, Coll Med, Asan Med Ctr, Dept Thorac & Cardiovasc Surg, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
- Lee, Jae Won교신저자Univ Ulsan, Coll Med, Asan Med Ctr, Dept Thorac & Cardiovasc Surg, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
- Kim, Joon Bum교신저자Univ Ulsan, Coll Med, Asan Med Ctr, Dept Thorac & Cardiovasc Surg, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
초록
© 2020 The American Association for Thoracic SurgeryObjective: We examined the safety and efficacy of del Nido cardioplegic solution compared with histidine-tryptophan-ketoglutarate cardioplegic solution in minimally invasive cardiac surgery. Methods: Patients who underwent minimally invasive cardiac surgery using del Nido or histidine-tryptophan-ketoglutarate from 2015 to 2019 were enrolled. Various clinical outcomes were compared between the groups. Postoperative laboratory findings including the levels of electrolytes, cardiac enzymes (creatine kinase-MB and troponin I), and serial blood lactate were also measured and compared. Based on 28 baseline covariates, propensity score matching was performed to reduce selection bias. Results: Among 766 patients, del Nido and histidine-tryptophan-ketoglutarate were used in 330 patients (43.1%) and 436 patients (56.9%), respectively. There were no significant intergroup differences in postoperative clinical outcomes and early adverse outcomes among 228 pairs of propensity score–matched patients. Immediate postoperative sodium levels were within the normal range in both groups without a significant difference (P = .50). However, peak creatine kinase-MB (median, 31.9 vs 37.7 ng/mL, P = .026) and troponin I (6.9 vs 9.1 ng/mL, P = .014) levels were significantly lower in the del Nido group. Linear regression analysis revealed a significant association between the peak cardiac enzyme levels and the cardiac ischemic time depending on the cardioplegia type, with lower cardiac isoenzymes for del Nido over histidine-tryptophan-ketoglutarate (P < .001) until the crossover point at the cardiac ischemic time over 100 minutes. Conclusions: In comparison with histidine-tryptophan-ketoglutarate solution, del Nido solution seems to have acceptable safety and efficacy with good myocardial protection in minimally invasive cardiac surgery. Further studies focusing on complex surgeries requiring longer cardiac ischemic time are needed.
키워드
adult cardiac surgerycardioplegic solutionminimally invasive cardiac surgerymyocardial protectionMYOCARDIAL PROTECTIONPEDIATRIC-PATIENTSTIME
식별자
- Scopus EID
- 2-s2.0-85099660309
- WoS UID
- 000889479300006



로그인
연구물 목록으로